Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Antiandrogens help manage PCOS symptoms but need careful monitoring.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

PCOS can cause unusual symptoms like late puberty and enlarged clitoris, making diagnosis difficult.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Raising awareness about PCOS can improve women's quality of life.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.